1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Financial - Capital Markets
UMF Group Inc.

UMF Group Inc.

UMFG
UMF Group Inc.US flagOther OTC
0.01
USD
+0.00
- -
36,754.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Bruce A. Thompson
Full Time Employees
4
Sector
Financial Services
Industry
Financial - Capital Markets
Address
1942 Broadway Street Boulder CO United States of America 80302
IPO Date
May 20, 2011
Website
umfgroupinc.com
Similar Companies
DeFi Technologies Inc. (DEFTF)
5paisa Capital Limited (5PAISA.BO)
Globlex Holding Management Public Company Limited (GBX.BK)
Yuhwa Securities co.,ltd. (003465.KS)
EZTD Inc. (EZTD)
Mentor Capital, Inc. (MNTR)
Business
UMF Group Inc. (UMFG) operates as a medical marijuana company focused on developing whole plant extractions for cancer and palliative treatments; its core offerings include cannabinoid-based pharmaceuticals and medical marijuana products targeting oncology and end-of-life care patients. The company serves healthcare providers and patients in the cannabis therapeutics segment, with operations based in the United States. Founded in 1988 and headquartered in Boulder, Colorado, UMF Group Inc. changed its name from American Community Development Inc. in February 2017 to reflect its strategic shift toward medical cannabis development.